COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
iTeos Therapeutics is a clinical-stage biotech developing immuno-oncology therapies that target the adenosine A2A pathway and regulatory T‑cell/TIGIT checkpoints, advancing EOS-850 and EOS-448 in clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
